CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
In: Blood Advances, Jg. 7 (2023-06-27), Heft 12, S. 2699-2708
Online
academicJournal
Zugriff:
Titel: |
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
|
---|---|
Autor/in / Beteiligte Person: | Akahoshi, Yu ; Nakasone, Hideki ; Takenaka, Katsuto ; Yamasaki, Satoshi ; Nakamura, Momoko ; Doki, Noriko ; Tanaka, Masatsugu ; Ozawa, Yukiyasu ; Uchida, Naoyuki ; Ara, Takahide ; Nakamae, Hirohisa ; Ota, Shuichi ; Onizuka, Makoto ; Yano, Shingo ; Tanaka, Junji ; Fukuda, Takahiro ; Kanda, Yoshinobu ; Atsuta, Yoshiko ; Kako, Shinichi ; Yanada, Masamitsu ; Arai, Yasuyuki |
Link: | |
Zeitschrift: | Blood Advances, Jg. 7 (2023-06-27), Heft 12, S. 2699-2708 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 2473-9529 (electronic) |
DOI: | 10.1182/bloodadvances.2022009376 |
Sonstiges: |
|